Regents of the University of California’s Regeneron Pharmaceuticals REGN Stock Holding History

Regents of the University of California’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-5,998	Closed	-$2.71M	–	63
2015 Q1	$2.71M	Sell	5,998 -1,600	-21%	-$678K	2.73%	7
2014 Q4	$3.12M	Buy	7,598 +1,998	+36%	+$786K	3.1%	3
2014 Q3	$2.02M	Sell	5,600 -800	-13%	-$268K	1.14%	42
2014 Q2	$1.81M	Buy	+6,400	New	+$1.9M	0.98%	57

Other funds holding REGN

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Regents of the University of California's REGN Position: Q2 2015 in Review

Regents of the University of California sold out of Regeneron Pharmaceuticals (REGN) in Q2 2015, closing a stake of 5,998 shares — an estimated $2.71M sold.

Regents of the University of California first reported a position in REGN in Q2 2014 and held it in 4 quarters. The position peaked at $3.12M in Q4 2014. 541 funds tracked by Wall St. Rank hold REGN as of Q2 2015.

Regents of the University of California reported no remaining Regeneron Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
Regents of the University of California sold 5,998 Regeneron Pharmaceuticals shares in Q2 2015, an estimated $2.71M.
Regents of the University of California first reported a position in Regeneron Pharmaceuticals in Q2 2014 and held it in 4 quarters.
Regents of the University of California's Regeneron Pharmaceuticals position peaked at $3.12M in Q4 2014.
541 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2015.

Based on Regents of the University of California's 13F filing for Q2 2015, filed 6 Aug 2015.